Talasaz AmirAli
Director, Co-Chief Executive Officer · 3 filings · Latest: May 12, 2026
Guardant Health, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GH | Talasaz AmirAli | Director, Co-Chief Executive Officer | May 12, 2026 | Sale | $100.32 | 50,000 | $5.0M | 2,096,504 | |
GH | Talasaz AmirAli | — | May 12, 2026 | Proposed Sale | $100.32 | 260,000 | $26.1M | — | |
GH | Talasaz AmirAli | Director, Co-Chief Executive Officer | Apr 1, 2026 | Option Exercise | $0.00 | 33,713 | — | 2,163,591 | |
GH | Talasaz AmirAli | Director, Co-Chief Executive Officer | Mar 31, 2026 | Option Exercise | $0.00 | 2,817 | — | 2,131,306 | |
GH | Talasaz AmirAli | Director, Co-Chief Executive Officer | Mar 13, 2026 | Option Exercise | $0.00 | 26,961 | — | 2,142,153 | |
GH | Talasaz AmirAli | Director, Co-Chief Executive Officer | Jan 1, 2026 | Option Exercise | $0.00 | 38,283 | — | 2,134,594 | |
GH | Talasaz AmirAli | — | Dec 8, 2025 | Proposed Sale | $105.05 | 100,000 | $10.5M | — | |
GH | Talasaz AmirAli | — | May 1, 2025 | Proposed Sale | $49.01 | 340,000 | $16.7M | — |